Strong and sustained share price appreciation, solid upside potential, an outlook toward further growth, and approval from Wall Street analysts characterize the three “monster growth stocks” highlighted in today’s article – all of which are hovering at or near one-year highs and have the potential to reach new highs. For these three stocks – including a developmental-stage biopharmaceutical company focused on developing drugs for the treatment of cancer – CLICK HERE.
“Monster Growth”: 3 Buy-Rated Stocks With The Potential To Reach New Highs
![](https://www.zenmoneynews.com/wp-content/uploads/2023/04/012-Real-estate-building-art-deco.jpeg)
Tags:Biopharmaceutical StocksBuy-Rated StocksInvestinvestorMonster Growth StocksStock MarketstocksWall Street Analysts